Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 1027-1035

  Quirós, Peter A ^a   Jones, Glenn W ^b   Kacinski, Barry M ^a   Braverman, Irwin M ^a   Heald, Peter W ^a   Edelson, Richard L ^a   Wilson, Lynn D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ontario Cancer Foundation   (Canada)

Author keywords

CTCL; Electron beam; Mycosis fungoides; PUVA; Radiation radiotherapy; TSEBT

Indexed keywords

METHOXSALEN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BEAM THERAPY; BLOOD TOXICITY; CANCER RECURRENCE; CANCER SURVIVAL; DRY SKIN; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PUVA; SKIN LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ELECTRONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASMS, SECOND PRIMARY; PUVA THERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SKIN NEOPLASMS;

EID: 0030857134     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00127-2     Document Type: Article

References (38)

1. Abel, E. A.; Deneau, D. G.; Farber, E. M.; Price, N. M.; Hoppe, R. T. PUVA treatment of erythrodermic and plaque type mycosis fungoides. J. Am. Acad. Dermatol. 4:423-429; 1981.
2. Abel, E. A.; Sendagorta, E.; Hoppe, R. T.; Hu, C. H. PUVA treatment of erythrodermic and plaque-type mycosis fungoides: Ten year follow-up. Arch. Dermatol. 123:897-901; 1987.
3. Braverman, I. M. Cutaneous T-cell lymphoma. Curr. Prob. Dermatol. 3:181-233; 1991.
4. Braverman, I. M.; Yager, N. B.; Chen, M.; Cadman, E. C.; Hait, W. N.; Maynard, T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. J. Am. Acad. Dermatol. 16:45-60; 1987.
5. Briffa, D. V.; Warin, A. P.; Harrington, C. I.; Bleehen, S. S. Photochemotherapy in mycosis fungoides: A study of 73 patients. Lancet ii:49-53; 1980.
6. Bunn, P. A.; Hoffman, S. J.; Norris, D.; Golitz, L. E.; Aeling, J. L. Systemic therapy of cutaneous T-cell lymphomas: Mycosis fungoides and the Sézary syndrome. Ann. Intern. Med. 121:592-602; 1994.
7. Bunn, P. A.; Lamberg, S. I. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat. Rep. 63:725-728; 1979.
8. Edelson, R. L.; Berger, C.; Gasparro, F.; Jegasothy, B.; Heald, P.; Wintroub, B.; Vonderheid, E.; Knobler, R.; Wolff, K.; Plewig, G., et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N. Engl. J. Med. 316:297-303; 1987.
9. Edelson, R. L.; Heald, P.; Perez, M.; Berger, C. Extracorporeal photochemotherapy. Biol. Ther. Cancer Updates 4:1-12; 1994.
10. Fuks, Z. Y.; Bagshaw, M. A. Total skin electron beam treatment of mycosis fungoides. Radiology 100:145-150; 1971.
11. Gilchrest, B. A. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat. Rep. 63:663-667; 1979.
12. Gupta, A. K.; Anderson, T. F. Psoralen photochemotherapy. J. Am. Acad. Dermatol. 17:703-734; 1987.
13. Haserick, J. R.; Richardson, J. H.; Grant, D. J. Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. Cleve. Clin. O. 26:144-147; 1990.
14. Heald, P.; Edelson, R. L. Photophoresis for T-cell mediated diseases. Adv. Dermatol. 3:25-40; 1988.
15. Herrmann, J. J.; Roenigk, H. H.; Hurria, A.; Kuzel, T. M.; Samuelson, E.; Rademaker, A. W.; Rosen, S. T. Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up. J. Am. Acad. Dermatol. 33:234-242; 1995.
16. Holloway, K. B.; Flowers, F. P.; Ramos-Caro, F. A. Therapeutic alternatives in cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 27:367-378; 1992.
17. Honigsmann, H.; Brenner, W.; Rauschmeier, W.; Konrad, K.; Wolff, K. Photochemotherapy for cutaneous T-cell lymphoma. A follow-up study. J. Am. Acad. Dermatol. 10:238-245; 1984.
18. Honigsmann, H.; Tanew, A.; Wolff, K. Treatment of mycosis fungoides with PUVA. Photodermatology 4:55-58; 1987.
19. Hoppe, R. T.; Abel, E. A.; Deneau, D. G.; Price, N. M. Mycosis fungoides: Management with topical nitrogen mustard. J. Clin. Oncol. 5:1796-1803; 1987.
20. Hoppe, R. T.; Cox, R. S.; Fuks, Z.; Price, N. M.; Bagshaw, M. A.; Farber, E. M. Electron beam therapy for mycosis fungoides: The Stanford University experience. Cancer Treat. Rep. 63:691-700; 1979.
21. Hoppe, R. T.; Fuks, Z.; Bagshaw, M. A. Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer Treat. Rep. 63:625-632; 1979.
22. Hoppe, R. T.; Wood, G. S.; Abel, E. A. Mycosis fungoides and the Sézary syndrome: Pathology, staging, and treatment. Curr. Prob. Cancer 15:293-371; 1990.
23. Jones, G. W.; Hoppe, R. T.; Glatstein, E. Electron beam treatment for cutaneous T-cell lymphoma. In: Koh, H. K.; Foss, F. M., eds. Hematology/oncology clinics of North America. Philadelphia: W. B. Saunders; 1995:1057-1076.
24. Jones, G.; McLean, J.; Rosenthal, D.; Roberts, J.; Sauder, D. N. Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and sezary syndrome) J. Am. Acad. Dermatol. 26:960-967; 1992.
25. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
26. Licata, A. G.; Wilson, L. D.; Braverman, I. M.; Feldman, A. M.; Kacinski, B. M. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma: The influence of additional therapy after total skin electron beam radiation. Arch. Dermatol. 131:432-435; 1995.
27. Lowe, N. J.; Cripps, D. J.; Dufton, P. A.; Vickers, C. F. Photochemotherapy for mycosis fungoides. Arch. Dermatol. 115:50-53; 1979.
28. Molin, L.; Thomsen, K.; Volden, G.; Groth, O. Photochemotherapy (PUVA) in the tumor stage of mycosis fungoides: A report from the Scandinavian mycosis fungoides study group. Acta. Dermatol. Venereol. 61:52-54; 1981.
29. Nasu, K.; Said, J.; Vonderheid, E.; Olerud, J.; Sako, D.; Kadin, M. Immunopathology of cutaneous T-cell lymphomas. Am. J. Pathol. 119:436-447; 1985.
30. Patterson, J. ; Edelson, R. Cutaneous T-cell lymphoma and other leukemic and lymphomatous infiltrates of the skin. In: Fitzpatrick, T. B.; Eisen, A. Z.; Wolff, K.; Arndt, K. A.; Van Scott, E. J.; Vaughan, J. H., eds. Dermatology in general medicine. New York: McGraw-Hill; 1987:1086-1118.
31. Powell, F. C.; Spiegel, G. T.; Muller, S. A. Treatment of parapsoriasis and mycosis fungoides: The role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin. Proc. 59:538-546; 1984.
32. Price, N. M.; Hoppe, R. T.; Constantine, F. S.; Fuks, Z. Y.; Farber, E. M. The treatment of mycosis fungoides: Adjuvant topical mechlorethamine after electron-beam therapy. Cancer 40:2851-2853; 1977.
33. Roenigk, H. H. Photochemotherapy for mycosis fungoides: Long-term follow-up study. Cancer Treat. Rep. 63:669-673; 1979.
34. Rosenbaum, M. M.; Roenigk, H. H.; Caro, W. A.; Esker, A. Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long term follow-up in 43 patients. J. Am. Acad. Dermatol. 13:613-622; 1985.
35. Spittle, M. F. Mycosis fungoides: Electron beam therapy in England. Cancer Treat. Rep. 63:639-641; 1979.
36. Swanbeck, G.; Roupe, G.; Sandstrom, M. H. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Dermatol. Venereol. 74:465-466; 1994.
37. Weinstock, M. A.; Horm, J. W. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 260:42-46; 1988.
38. Wilson, L. D.; Cooper, D. L.; Goodrich, A. L.; Friedman, N. D.; Feldman, A. M.; Braverman, I. M.; Kacinski, B. M. Impact of non-CTCL dermatologie diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:829-837; 1994.